Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spero Therapeutics Inc 675 Massachusetts Avenue 14th Floor Cambridge MA 02139 USA

https://sperotherapeutics.com Employees: 25 P: 857-242-1600

Sector:

Medical

Description:

Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.

Key Statistics

Overview:

Market Capitalization, $K 160,937
Enterprise Value, $K 120,667
Shares Outstanding, K 57,891
Float, K 54,707
% Float 94.50%
Short Interest, K 605
Short Float 1.05%
Days to Cover 1.86
Short Volume Ratio 0.41
% of Insider Shareholders 5.50%
% of Institutional Shareholders 25.60%

Financials:

Annual Sales, $ 66,800 K
Annual Net Income, $ 8,570 K
Last Quarter Sales, $ 41,300 K
Last Quarter Net Income, $ 31,520 K
EBIT, $ 6,320 K
EBITDA, $ 6,320 K

Growth:

1-Year Return 258.01%
3-Year Return 63.53%
5-Year Return -78.91%
5-Year Revenue Growth 615.97%
5-Year Earnings Growth 104.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.53 on 03/26/26
Next Earnings Date 05/12/26 [--]
Earnings Per Share ttm 0.12
EPS Growth vs. Prev Qtr 507.69%
EPS Growth vs. Prev Year 239.47%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 09/16/15
Dividend Payout Ratio 0.00%

SPRO Ratios

Ratio
Price/Earnings ttm 23.17
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 22.53%
Return-on-Assets % 13.04%
Profit Margin % 12.83%
Debt/Equity 0.00
Price/Sales 2.41
Price/Cash Flow 18.27
Price/Book 2.65
Book Value/Share 1.05
Interest Coverage -1.40
60-Month Beta 1.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.